Yeast-based vaccine shows promise in clinical PPV study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      Our vaccine platform allows to develop safe and polyvalent vaccines in a record time and at comparably very low costs." serYmun Yeast will be present at the Animal Health, Nutrition and Technology Innovation Conference in London, March 5-8, 2023. SerYmun Yeast GmbH, an animal health vaccine development company based in Germany, has announced a breakthrough in the development of their first pig vaccine candidate against porcine parvovirus. [Extracted from the article]
    • Abstract:
      Copyright of National Hog Farmer Exclusive Insight is the property of Penton Media, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)